Evidence map›Paper›PMID 29602771›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Transcriptomic Analysis of CD4

Julie G Burel, Cecilia S Lindestam Arlehamn, Nabeela Khan, Grégory Seumois, Jason A Greenbaum, Randy Taplitz, Robert H Gilman, Mayuko Saito, Pandurangan Vijayanand, Alessandro Sette and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Immunodominant Tuberculosis Antigens Recognized by Human CD4Cold Spring Harbor perspectives in medicine · 2026
    Article
  3. Article
  4. Article
  5. The Complex Dysregulations of CD4 T Cell Subtypes in HIV Infection.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. High and Low Levels ofInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The Biological and Clinical Aspects of a Latent Tuberculosis Infection.Tropical medicine and infectious disease · 2022
    Review
  14. Using Omics to Study Leprosy, Tuberculosis, and Other Mycobacterial Diseases.Frontiers in cellular and infection microbiology · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Julie G BurelDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; jburel@lji.org.ORCID 0000-0003-1692-2758
Cecilia S Lindestam ArlehamnDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Nabeela KhanDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.ORCID 0000-0003-3090-3772
Grégory SeumoisDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.ORCID 0000-0002-8164-6852
Jason A GreenbaumDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.ORCID 0000-0002-1381-0390
Randy TaplitzDivision of Infectious Diseases, University of California, San Diego, La Jolla, CA 92093.ORCID 0000-0002-0109-5991
Robert H GilmanJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205.
Mayuko SaitoJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205.ORCID 0000-0003-4622-7027
Pandurangan VijayanandDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Alessandro SetteDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.ORCID 0000-0001-7013-2250
Bjoern PetersDepartment of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.ORCID 0000-0002-8457-6693
La Jolla Institute for Immunology · USJohns Hopkins University · USUniversity of California San Diego · US

Funding

Single-cell atlas of lung tissue-resident memory T cells reactive to upper and lower respiratory tract pathogensU19AI118626 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Alessandro Sette · 2015 to 2026
$36.7M
CyTOF Mass CytometerS10OD018499 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROTTY, SHANE P · 2014 to 2014
$802k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NIAID NIH HHS U19 AI118626NIH HHS S10 OD018499
6 · The paper itself

Abstract

In the context of infectious diseases, cell population transcriptomics are useful to gain mechanistic insight into protective immune responses, which is not possible using traditional whole-blood approaches. In this study, we applied a cell population transcriptomics strategy to sorted memory CD4 T cells to define novel immune signatures of latent tuberculosis infection (LTBI) and gain insight into the phenotype of tuberculosis (TB)-specific CD4 T cells. We found a 74-gene signature that could discriminate between memory CD4 T cells from healthy latently

Indexed as

AdultCD4-Positive T-LymphocytesGene Expression ProfilingHumansLatent TuberculosisMaleTranscriptome

Identifiers

PMID29602771
PMCPMC5991485
OpenAlexW2795199576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.